• LAST PRICE
    0.2144
  • TODAY'S CHANGE (%)
    Trending Up0.0072 (3.4749%)
  • Bid / Lots
    0.2077/ 9
  • Ask / Lots
    0.2144/ 3
  • Open / Previous Close
    0.2100 / 0.2072
  • Day Range
    Low 0.2076
    High 0.2250
  • 52 Week Range
    Low 0.1600
    High 1.0800
  • Volume
    701,324
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.2072
TimeVolumeACRX
09:32 ET78580.2077
09:34 ET41500.2108
09:36 ET30840.213999
09:38 ET6000.2109
09:39 ET74240.214
09:41 ET17460.2101
09:43 ET13300.214
09:50 ET5580.2101
09:52 ET2000.2101
09:54 ET171540.21175
09:56 ET7000.2103
09:59 ET99100.2109
10:01 ET15500.210899
10:03 ET3130.2108
10:06 ET16450.2101
10:08 ET31700.21005
10:10 ET73550.20775
10:12 ET61920.2077
10:14 ET41880.2121
10:15 ET16720.212
10:17 ET7350.2121
10:21 ET12000.2121
10:24 ET24000.2121
10:28 ET31800.2121
10:30 ET1000.210799
10:32 ET11000.2108
10:33 ET107720.2102
10:35 ET6500.210117
10:37 ET75930.2108
10:39 ET64430.2108
10:50 ET86140.2129
10:51 ET101000.212
10:53 ET10000.2129
10:55 ET597070.2129
10:57 ET308760.2147
11:00 ET230000.2147
11:02 ET107000.2147
11:04 ET600410.2235
11:06 ET67840.2248
11:08 ET37000.2248
11:09 ET6000.2247
11:11 ET17000.22
11:13 ET4000.2246
11:15 ET890710.216
11:18 ET79750.2189
11:20 ET16000.2189
11:22 ET5000.219
11:26 ET3000.219
11:27 ET22000.2165
11:29 ET20000.2153
11:31 ET26170.2165
11:33 ET15000.2179
11:36 ET47000.2233
11:38 ET9000.2233
11:40 ET7780.2204
11:44 ET80000.2238
11:45 ET87280.2225
11:47 ET7600.224999
11:49 ET70520.2212
11:51 ET165280.2151
11:58 ET1000.2151
12:03 ET61000.2151
12:07 ET10000.2151
12:12 ET8000.2151
12:20 ET11000.2151
12:21 ET9000.2151
12:23 ET5000.2151
12:27 ET6000.2151
12:34 ET6070.215
12:36 ET23000.2151
12:38 ET399980.2151
12:41 ET2120.2151
12:54 ET12000.2149
12:56 ET10000.214999
01:01 ET6000.215
01:06 ET1000.215
01:12 ET1410.2125
01:15 ET44200.215
01:17 ET3000.215
01:26 ET4500.2149
01:30 ET1000.2149
01:32 ET2700.214818
01:42 ET29000.2148
01:44 ET1130.2148
01:46 ET75910.2148
01:51 ET1000.2148
01:55 ET13000.2147
01:57 ET1600.21
02:00 ET1400.2128
02:04 ET1000.2147
02:08 ET10460.2147
02:11 ET111000.2173
02:13 ET1000.2173
02:15 ET4000.2161
02:18 ET24280.2197
02:22 ET11500.2197
02:24 ET30000.214
02:26 ET14000.22
02:29 ET5000.225
02:33 ET1000.2249
02:38 ET12000.218
02:42 ET1000.2249
02:44 ET1000.2249
02:49 ET360000.2246
02:51 ET3000.2246
02:56 ET12140.2145
03:09 ET15500.2146
03:14 ET104100.2146
03:20 ET8000.2172
03:23 ET9000.2145
03:25 ET26000.2179
03:27 ET59510.21795
03:30 ET24000.2169
03:32 ET1000.21555
03:34 ET2000.215
03:36 ET40850.2144
03:38 ET5000.2145
03:39 ET5000.2145
03:41 ET4000.2145
03:43 ET4000.2145
03:45 ET5000.2144
03:48 ET25240.2145
03:50 ET10000.2145
03:52 ET11000.2145
03:54 ET12000.2145
03:56 ET64000.2145
03:57 ET12000.2145
03:59 ET8800.2144
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACRX
AcelRx Pharmaceuticals Inc
30.5M
0.7x
---
United StatesCYCN
Cyclerion Therapeutics Inc
36.5M
-0.8x
---
United StatesVTGN
VistaGen Therapeutics Inc
31.3M
-0.5x
---
United StatesBCDA
BioCardia Inc
35.2M
-2.9x
---
United StatesENTX
Entera Bio Ltd
34.0M
-21.3x
---
United StatesMBOT
Microbot Medical Inc
33.8M
-2.5x
---
As of 2022-09-28

Company Information

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio of products and product candidates consists of sufentanil sublingual products and product candidates, pre-filled syringe product candidates and nafamostat mesylate product candidates. Its sufentanil sublingual products include DSUVIA, DZUVEO and Zalviso, which are focused on the treatment of moderate-to-severe acute pain in a medically supervised setting. Its pre-filled syringe product candidates include Ephedrine and Phenylephrine. Its nafamostat mesylate product candidates include Niyad, which is a regional anticoagulant for injection into the extracorporeal circuit, and LTX-608, which is a nafamostat formulation for antiviral treatment of COVID, acute respiratory distress syndrome (ARDS), disseminated intravascular coagulation (DIC), and acute pancreatitis.

Contact Information

Headquarters
25821 Industrial Boulevard, Suite 400HAYWARD, CA, United States 94545
Phone
650-216-3500
Fax
650-216-6500

Executives

Independent Chairman of the Board
Adrian Adams
Chief Executive Officer, Director
Vincent Angotti
Co-Founder, Director, Chief Medical Officer
Pamela Palmer
Chief Financial Officer
Raffi Asadorian
Chief Engineering Officer
Badri Dasu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$30.5M
Revenue (TTM)
$2.9M
Shares Outstanding
147.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.38
EPS
$0.29
Book Value
$-0.26
P/E Ratio
0.7x
Price/Sales (TTM)
10.6
Price/Cash Flow (TTM)
0.6x
Operating Margin
-1,369.12%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.